- Filed
- Mar 27, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Mar 26, 2024 | 1.15M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2023 | 486.58K sh |
| Shares Diluted | Q2 2024 · Dec 31, 2023 | 277.51K sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 1.83K sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 1.47K sh |
| Dividends Paid | Q2 2024 · Dec 31, 2023 | $334.38K |
| Dividends Paid | Q2 2024 · Dec 31, 2022 | $401.26K |
| Operating Cash Flow | Q2 2024 · Dec 31, 2023 | −$4.08M |
| Operating Cash Flow | Q2 2024 · Dec 31, 2022 | −$8.54M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $1.1M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $1.75M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2022 | $682.38K |
| Cash And Equivalents | Q2 2024 · Jun 30, 2022 | $2.52M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | −$16.75M |
| Stockholders Equity | Q2 2024 · Sep 30, 2023 | $407.81K |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $4.8M |
| Stockholders Equity | Q2 2024 · Dec 31, 2022 | −$25.8M |
| Stockholders Equity | Q2 2024 · Sep 30, 2022 | −$16.08M |
| Stockholders Equity | Q2 2024 · Jun 30, 2022 | −$11.6M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $12.43M |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $8.86M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $12.52M |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $9.22M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $4.67M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $4.04M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $7.6M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $22.1M |
| Eps Diluted | Q2 2024 · Dec 31, 2023 | −$64.55 |
| Eps Diluted | Q2 2024 · Dec 31, 2023 | −$180.08 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$7,873.53 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$12,824.71 |
| Eps Basic | Q2 2024 · Dec 31, 2023 | −$64.55 |
| Eps Basic | Q2 2024 · Dec 31, 2023 | −$180.08 |
| Eps Basic restated | Q2 2024 · Dec 31, 2022 | −$7,873.53 |
| Eps Basic restated | Q2 2024 · Dec 31, 2022 | −$12,824.71 |
| Sga Expense | Q2 2024 · Dec 31, 2023 | $4.78M |
| Sga Expense | Q2 2024 · Dec 31, 2023 | $10.97M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $7.56M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $17.03M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$17.05M |
| Net Income | Q2 2024 · Dec 31, 2023 | −$21.85M |
| Net Income | Q2 2024 · Sep 30, 2023 | −$4.8M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$14.13M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$18.3M |
| Net Income | Q2 2024 · Sep 30, 2022 | −$4.17M |
| Operating Income | Q2 2024 · Dec 31, 2023 | −$16.53M |
| Operating Income | Q2 2024 · Dec 31, 2023 | −$21.54M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$21.5M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$27.56M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2023 | $688.53K |
| Cost Of Revenue | Q2 2024 · Dec 31, 2023 | $1.29M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $2.37M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $6.12M |
| Revenue | Q2 2024 · Dec 31, 2023 | $2.58M |
| Revenue | Q2 2024 · Dec 31, 2023 | $5.27M |
| Revenue | Q2 2024 · Dec 31, 2022 | $6.41M |
| Revenue | Q2 2024 · Dec 31, 2022 | $16.01M |
| Capex | Q2 2024 · Dec 31, 2022 | $3.32K |